Avanos Medical Inc (AVNS)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands -383,000 57,700 46,900 28,700 23,900 27,900 45,400 66,500 73,100 71,900 56,800 30,500 8,900 -60,900 -64,600 -59,100 -46,100 -4,500 -22,500 -30,500
Revenue (ttm) US$ in thousands 687,800 681,500 682,400 680,100 705,700 749,900 780,700 814,300 820,000 795,900 777,900 761,300 744,600 736,200 737,800 715,100 714,800 719,600 705,300 713,800
Operating profit margin -55.68% 8.47% 6.87% 4.22% 3.39% 3.72% 5.82% 8.17% 8.91% 9.03% 7.30% 4.01% 1.20% -8.27% -8.76% -8.26% -6.45% -0.63% -3.19% -4.27%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-383,000K ÷ $687,800K
= -55.68%

Avanos Medical Inc's operating profit margin has shown a fluctuating trend over the past few years. The margin started in negative territory in 2020, steadily improving to positive levels by 2022. However, there was a significant decline in the operating profit margin in the fourth quarter of 2024, dropping to -55.68%. This sudden decrease raises concerns about the company's profitability and operational efficiency during that period. Overall, the company needs to closely monitor and manage its operating expenses and revenues to sustain and enhance its operating profit margin in the future.